Holdings
B Group, Inc.
As of Sep 30, 2026, B Group, Inc. reported 19 positions worth US$162M. Largest: ADMA Biologics Inc, Sensei Biotherapeutics, Inc. and Palisade Bio, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| ADMA Biologics Inc | 3.26M | US$32.7M | no change | Sep 30, 2026 |
| Sensei Biotherapeutics, Inc. | 610K | US$18.1M | no change | Sep 30, 2026 |
| Palisade Bio, Inc. | 11.4M | US$15.4M | no change | Sep 30, 2026 |
| NRX Pharmaceuticals, Inc. | 4.28M | US$12.5M | +185K | Sep 30, 2026 |
| Zai Lab Ltd. | 451K | US$11.9M | no change | Sep 30, 2026 |
| Praxis Precision Medicines, Inc. | 33,237 | US$9.68M | no change | Sep 30, 2026 |
| Sight Sciences, Inc. | 970K | US$9.08M | no change | Sep 30, 2026 |
| Taysha Gene Therapies, Inc. | 1.8M | US$8.77M | no change | Sep 30, 2026 |
| Iovance Biotherapeutics, Inc. | 425K | US$6.3M | −1.07M | Sep 30, 2026 |
| Structure Therapeutics, Inc. | 180K | US$5.63M | new | Sep 30, 2026 |